Tracking Service Use and Outcomes II:First Episode Psychosis and Psychotic Disorders Clinic

September 12, 2006 updated by: Hamilton Health Sciences Corporation

Main Research questions:

  1. Who are the patients referred for treatment at the Psychotic Disorders Clinic?
  2. What are the outcomes from treatment for first episode psychosis in multiple outcome domains?
  3. What hospital resources are used over the early course of the illness?
  4. How satisfied are patients and family with the treatment and services they received? This is an important study that will help us evaluate the service and treatment offered by the Psychotic Disorders Clinic's specialized early intervention program,which helps young people experiencing early stages of psychotic illness.A growing body of evidence suggests that intervening earlier in the course of the illness with specialized and complimentary pharmacological and psychosocial treatment may be associated with improved outcomes.

Study Overview

Status

Terminated

Conditions

Detailed Description

The project is primarily a descriptive study of individuals experiencing their first episode of psychosis presenting at the Psychotic Disorders Clinic/Early Intervention Program.

The objectives of the study are:

  1. Track multi-dimensional outcomes within the program
  2. Track service use
  3. Compare outcomes for this early intervention program with outcomes noted in published follow up studies
  4. Evaluate effectiveness of the Psychotic Disorders Clinic in improving outcomes for persons experiencing their first episode of psychosis

Study Type

Observational

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Canada
    • Ontario
      • Hamilton, Ontario, Canada, L8N 1Y2
        • Cleghorn Program-Early Intervention in Psychosis.St Joseph's Healthcare Hamilton/Hamilton Health Sciences

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 50 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • male or female between ages of 16 to 50 years of age
  • capable of providing informed consent
  • receiving treatment voluntarily
  • experiencing a "first episode of psychosis" defined as the first episode of illness and where the subject,at presentation,meets DSM-IV criteria for one of the following diagnoses:schizophrenia,schizophreniform disorder,schizoaffective disorder,brief psychotic disorder,delusional disorder,and psychosis NOS

Exclusion Criteria:

  • primary diagnosis of mood disorder
  • diagnosis of substance-induced psychosis
  • diagnosis of psychosis due to a general medical condition
  • diagnosis of mental retardation
  • diagnosis of developmental disorder
  • has received antipsychotic treatment for greater than 1 month
  • has received treatment for an earlier episode of psychosis from which there has been a remission of symptoms for greater than 3 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Defined Population
  • Time Perspectives: Prospective

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Hamilton Health Sciences Corporation

Investigators

  • Principal Investigator: Suzanne Archie, MD,FRCP(C), Assistant Professor Dept of Psychiatry and Behavioural Neurosciences McMaster University.Active Medical Staff Hamilton Health Sciences.Clinical Director of Cleghorn Early Intervention in Psychosis Program and Psychotic Disorders Clinic

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2004

Study Registration Dates

First Submitted

November 1, 2005

First Submitted That Met QC Criteria

November 1, 2005

First Posted (Estimate)

November 3, 2005

Study Record Updates

Last Update Posted (Estimate)

September 13, 2006

Last Update Submitted That Met QC Criteria

September 12, 2006

Last Verified

September 1, 2006

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • REB #04-203

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Schizophreniform,First Episode Psychosis

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Czech Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe